IRCT2012121311743N1已完成未知
Comparison of the effects of Losartan with combination of Losartan and pyridoxamine on proteinuria in type 2 diabetic patients
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 44
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 70 years（—）
- 性别
- All
入选标准
- •(to be 18 to 70 years old; to have type 2 diabetes; 24 hours urine albumin more than 300 mg/dl or to have a albumin to creatinine ratio of more than 30; not to have a nephropathy due to other diseases)
- •Exclusion criteria: (patients with advanced cardiac or cerebral diseases; to have a history of diabetic ketoacidosis and to have a history of sensitivity to the Vitamin B group drugs)
排除标准
- 未提供
研究者
相似试验
已完成
4 期
Effects of Different Losartan Combination Antihypertensive Therapy in CKD PatientsChronic kidney disease patients complicated with hypertensionJPRN-UMIN000004062agoya University CKD Clinical Cooperation System Study Group120
进行中（未招募）
1 期
Effects of Losartan versus Nebivolol versus the association of both on the progression of aortic root dilation in Marfan Syndrome (MFS) with FBN1 gene mutations - NDMedDRA version: 9.1Level: LLTClassification code 10026829Term: Marfan's syndromeMarfan SyndromeEUCTR2008-001462-81-ITOSPEDALE POLICLINICO S. MATTEO
已完成
不适用
The evaluation of the effect of losartan on central blood pressure via sympathetic tone and endothelial functioHypertensionJPRN-UMIN000005653The Second Department of Internal Medicine Tokyo Medical University50
招募中
不适用
Bioequivalence Evaluation of Losartan and Cozaar® formulations in healthy volunteersIRCT20130603013572N5Daana pharma.Co26
已完成
3 期
Investigation Effect of losartan NAFLD patientsAFLD.Fatty (change of) liver, not elsewhere classifiedK76.0IRCT20180412039283N1Shahid Beheshti University of Medical Sciences250